Stocks and Investing Stocks and Investing
Wed, May 8, 2024
Tue, May 7, 2024

Andrew Fein Reiterated (BCRX) at Strong Buy and Held Target at $30 on, May 7th, 2024


Published on 2024-10-28 11:05:05 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "BioCryst Pharmaceuticals, Inc." (BCRX) at Strong Buy and Held Target at $30 on, May 7th, 2024.

Andrew, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources